Skip to main content
. 2016 Dec 15;2016(12):CD006918. doi: 10.1002/14651858.CD006918.pub3

Litman 2014.

Methods Allocation: randomised.
 Blindness: double blind.
Duration: 28 days.
 Design: parallel.
Participants Diagnosis: people with schizophrenia.
N = 151.
Age: not reported.
Sex: not reported.
Interventions 1. Risperidone: 4 mg. 
 2. Placebo.
3. AZD8529: 40 mg.
Outcomes Unable to use:
PANSS, CGI.
Notes Full text is not available.